Assessment of the Prognostic Role of Ki-67 and Its Optimal Cutoff Value in Early Breast Cancer: A Retrospective Analysis

Evaluation of the Prognostic Value of Ki-67 in Early-Stage Breast Cancer

STUDY THE PROGNOSTIC VALUE OF INFLAMMATORY BLOOD MARKER FOR OVERALL SURVIVAL IN NON-METASTATIC BREAST CANCER

EVALUATION OF KI67 PREDICTIVE ROLE AND ITS DISCORDANCE BETWEEN PRETHERAPY BIOPSY AND POST THERAPY SURGICAL SPECIMEN IN BREAST CANCER PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY.

COX-2 “Cyclooxygenase 2“as a Prognostic marker in Breast Cancer

Clinical Prognostic Factors in Breast Cancer

The prognostic value of P53 and CA15.3 tumor markers in breast cancer patient

Assessment of Response to Hormonal Therapy by Serum Ki-67 as a Biomarker in Non-metastatic Hormone Positive Breast Cancer: A Prospective Study

Quantitative Analysis of C-erbB2 and P53 Protein Levels in Breast Tumor Tissues and Study of Their Associations with Tumor biological Characteristics and Prognosis

ASSESMENT OF PROGNOSTIC VALUE OF METASTATIC FREE INTERVAL AS OVERALL SURVIVAL SURROGATE IN METASTATIC BREAST CANCER FEMALE PATIENTS